Project Grant K99ES037399
- Federal Project Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded the Regents of the University of Michigan a $3.13 million Project Grant under the Environmental Health program (CFDA 93.113) on September 10, 2025, with completion anticipated by September 9, 2029. The research initiative, conducted at the University of Michigan's Ann Arbor campus, aims to integrate exposome and epigenome analyses to identify determinants of amyotrophic lateral sclerosis...
- Federal Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded a $157,500 Project Grant to the Regents of the University of California at Riverside on July 9, 2025, under the Environmental Health program (CFDA 93.113). This two-year award (completion date: July 8, 2027) funds pilot research investigating gene-environment interactions in autism spectrum disorder (ASD) risk through developmental exposure to per- and polyfluoroalkyl substances (PFAS), commonly...
- Federal Grant Award Summary Black Hills State University received a $484,122 Project Grant from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113), awarded on August 20, 2025, with completion targeted for July 31, 2028. The grant funds research investigating the mechanisms of neurotoxicity induced by beta-methylamino-L-alanine (BMAA), a cyanobacteria biotoxin linked to amyotrophic lateral sclerosis/parkinsonism-dementia complex...
- Federal Project Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded a $749,640 Project Grant to the University of California, Davis, effective April 1, 2026 through March 31, 2031, to conduct research investigating the interplay between TET1-mediated epigenomic mechanisms and N6-methyladenosine (m6A) RNA modification in pulmonary inflammation induced by particulate matter (PM) exposure. Under the Environmental Health program (CFDA 93.113), the research...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Nevada, Reno a $387,525 Project Grant effective June 3, 2025, through May 31, 2027, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The research project investigates proton-mediated signaling at the neuromuscular junction in amyotrophic lateral sclerosis (ALS) models to advance understanding of motor neuron degeneration...
- Federal Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded $814,154 under the Environmental Health program (CFDA 93.113) to The Research Foundation For The State University of New York at the University at Albany, effective April 1, 2026 through March 31, 2031. This Project Grant supports research investigating the interplay between the epitranscriptome and epigenome in regulating cellular responses to toxicants, with a focus on naphthalene, a major...
- Federal Project Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded UCLA a $409,687 Project Grant (CFDA 93.113, Environmental Health program) on June 24, 2025, with completion targeted for June 13, 2027. This research initiative delivers a comprehensive epidemiological investigation examining the impacts of wildfire smoke and heat exposure on cognitive decline, mood disorders, and metabolic changes in older adults with Parkinson's Disease (PD)....
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $460,625 to the University of Massachusetts Medical School on June 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support a two-year research investigation through May 31, 2027. The project, titled "Investigating the Role of TDP-43 Citrullination in ALS Pathogenesis," focuses on understanding how...
- Federal Project Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health program (CFDA 93.113), awarded $931,568 to the University of California, Irvine on August 1, 2025, for a five-year research project extending through May 31, 2030. This investigator-initiated research project identifies environmental factors contributing to rising mental-emotional-behavioral (MEB) disorders in urban-dwelling children and maternal postpartum...
- Federal Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded the University of Louisville a $3.05 million Project Grant (CFDA 93.113, Environmental Health program) on September 11, 2025, for research investigating RNA modifications in apolipoprotein regulation under environmental exposures. The research will examine how exposure to polychlorinated biphenyls (PCBs)—persistent environmental contaminants—contributes to metabolic dysfunction-associated...
The National Institute of Environmental Health Sciences (NIEHS) awarded UC Riverside a $120,663 Project Grant (CFDA 93.113: Environmental Health program) effective April 1, 2026, through March 31, 2028, to conduct mechanistic research on how environmental exposures alter RNA pseudouridylation and subsequent RNA-protein interactions in the context of amyotrophic lateral sclerosis (ALS) pathogenesis. The research deliverables include three specific research aims: (1) examining how RNA pseudouridylation is modulated by xenobiotic exposure in human neuronal cells; (2) investigating transcriptome-wide occupancy impacts of ALS-associated proteins influenced by RNA pseudouridylation; and (3) exploring the functional impacts of RNA pseudouridylation and pseudouridine-protein interactions in xenobiotic and ALS pathological contexts. This investigation is designed to bridge existing knowledge gaps regarding the mechanistic link between environmental exposure and ALS through the lens of RNA modification and protein-RNA binding dynamics. The project builds upon preliminary data demonstrating that ALS-linked mutations in profilin-1 reduce its affinity for pseudouridine-containing RNA, suggesting that environmental exposure-mediated aberrant RNA pseudouridylation constitutes a major regulatory mechanism underlying neurodegenerative disease pathogenesis. The research outputs will advance understanding of how environmental xenobiotic exposure alters fundamental RNA processes and protein interactions relevant to ALS development and may inform future intervention strategies for environmental health-related neurological disease.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $120.7k | 4/1/26 |